Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma

[1]  P. Rougier,et al.  Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Stockler,et al.  Use of tamoxifen in advanced‐stage hepatocellular carcinoma , 2005, Cancer.

[3]  J. Llovet,et al.  Updated treatment approach to hepatocellular carcinoma , 2005, Journal of Gastroenterology.

[4]  A. Burroughs,et al.  Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. , 2004, The Lancet. Oncology.

[5]  K. Soo,et al.  High‐dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial , 2002, Hepatology.

[6]  S. Pignata,et al.  Hepatocellular Carcinoma: Systemic Treatments , 2002, Journal of clinical gastroenterology.

[7]  S. Pignata,et al.  Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial. , 2002, Current pharmaceutical design.

[8]  S. Assmann,et al.  Subgroup analysis and other (mis)uses of baseline data in clinical trials , 2000, The Lancet.

[9]  F. Izzo,et al.  A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients , 1998, Hepatology.

[10]  S. Pignata,et al.  Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial , 1998, The Lancet.

[11]  Wolfgang Greiner,et al.  Health Technology Assessment (HTA) , 2008 .

[12]  O. Seror,et al.  Local/regional and systemic treatments of hepatocellular carcinoma. , 2005, Seminars in liver disease.

[13]  T. Peters,et al.  Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. , 2001, Health technology assessment.

[14]  Bellia Mario,et al.  Prospective validation of the CLIP score, a new prognostic system for cirrhotic patients with hepatocellular carcinoma (RE: Hepatology 2000, 32/3: 679-80) , 2000 .